| Carfilzomib or bortezomib with melphalan-prednisone for transplant-ineligible patients with newly diagnosed multiple myeloma T Facon, JH Lee, P Moreau, R Niesvizky, M Dimopoulos, R Hajek, L Pour, ... Blood, The Journal of the American Society of Hematology 133 (18), 1953-1963, 2019 | 116 | 2019 |
| Nonparametric regression models for right-censored data using Bernstein polynomials M Osman, SK Ghosh Computational Statistics & Data Analysis 56 (3), 559-573, 2012 | 53 | 2012 |
| Phase 3 study (CLARION) of carfilzomib, melphalan, prednisone (KMP) v bortezomib, melphalan, prednisone (VMP) in newly diagnosed multiple myeloma (NDMM) T Facon, JH Lee, P Moreau, R Niesvizky, MA Dimopoulos, R Hajek, ... Clinical Lymphoma Myeloma and Leukemia 17 (1), e26-e27, 2017 | 44 | 2017 |
| Semiparametric Bayesian testing procedure for noninferiority trials with binary endpoints M Osman, SK Ghosh Journal of Biopharmaceutical Statistics 21 (5), 920-937, 2011 | 14 | 2011 |
| Randomized phase 3 study of carfilzomib or bortezomib with melphalan-prednisone for transplant-ineligible, NDMM patients T Facon, JH Lee, P Moreau Blood 133 (18), 1953-1963, 2019 | 10 | 2019 |
| Remote weather associated with North Pacific subtropical sea level high properties R Grotjahn, M Osman International Journal of Climatology: A Journal of the Royal Meteorological …, 2007 | 10 | 2007 |
| Phase 2a study of the dual SYK/JAK inhibitor cerdulatinib (ALXN2075) as monotherapy in patients with relapsed/refractory peripheral T-cell lymphoma SM Horwitz, TA Feldman, CY Jing, MS Khodadoust, J Munoz, PA Hamlin, ... Blood 138, 622, 2021 | 8 | 2021 |
| Phase 2a study of the dual SYK/JAK inhibitor cerdulatinib (ALXN2075) as monotherapy or in combination with rituximab in patients with Relapsed/Refractory follicular lymphoma PA Hamlin, MR Patel, D Stevens, BT Hess, J Munoz, TA Feldman, ... Blood 138, 2423, 2021 | 6 | 2021 |
| Novel Bayesian methods for non-inferiority tests based on relative risk and odds ratio for dichotomous data M Osman, SK Ghosh Journal of Statistical Theory and Practice 4, 433-452, 2010 | 3 | 2010 |
| Preliminary Results of a Phase 1, Dose-Escalation Study of PRT2527, a Potent and Highly Selective CDK9 Inhibitor, As Monotherapy and in Combination with Zanubrutinib in … KL Lewis, W Jurczak, GP Gregory, CS Tam, WS Kim, EA Hawkes, ... Blood 144, 4501, 2024 | | 2024 |
| Bayesian Noninferiority Testing and Nonparametric Survival Regression using Bernstein Polynomials. M Osman | | 2011 |
| Remote Weather Associated with North Pacific Subtropical Sea Level High Properties NPS High, R Grotjahn, M Osman | | 2005 |
| POWER AND ROBUSTNESS OF NONPARAMETRIC COVARIATE ADJUSTMENT METHODS FOR ORDINAL DATA M OSMAN, WEI TIAN | | |
| Performance of Bayesian methods in non-inferiority tests based on relative risk and odds ratio for dichotomous data M Osman, SK Ghosh | | |
